Nationwide vaccination recommended for tick-borne encephalitis
Tick-borne encephalitis (TBE) cases have significantly increased in 2018, and areas of high risk continue to expand. The Swiss government is considering issuing a nationwide vaccination recommendation against the virus.
This content was published on
3 minutes
SRF-RTS/ln
Almost 230 people have already been infected with the virus – which in rare cases can be fatal – since the beginning of 2018, reported Swiss Public Television, SRF, on Tuesday.
Cases have almost doubled compared to last year’s figures for the same time period.
In addition, the at-risk areas, where the disease is endemic, are increasing, according to the Federal Office of Public Health.
The Zurich area, all of north-eastern Switzerland and large parts of cantons Bern and Aarau are all affected by the virus.
It makes little sense to recommend vaccination against the TBE virus only for certain at-risk regions, Christoph Berger, President of the Swiss Federal Commission for Vaccination, told SRF.
“These areas are almost merging into each other. At some point, it becomes more reasonable and easier to make a general, nationwide vaccination recommendation,” he said.
The commission had already set up a working group to consider whether the vaccination recommendation should be extended to all of Switzerland except for the canton of Ticino. So far, no cases of tick-born encephalitis have been recorded in the Italian-speaking canton.
Health insurance coverage
Such a recommendation would oblige health insurance companies to cover the costs of the vaccination across Switzerland, not just for people who live in an at-risk zone.
Complete protection against the virus requires three vaccinations spread over several months.
The cost of preventing diseases such as meningitis or encephalitis which can be caused by the TBE virus would be much lower than dealing with the complications and permanent physical damage these illnesses may cause, according to Berger.
The recommendations could come into force for the whole of German- and French-speaking Switzerland next year, said Berger. His expert commission will submit a proposal to the federal government; health minister Alain Berset will take the final decision.
Dangerous symptoms
In Switzerland, the tick season starts in March and ends in June, depending on the weather. The health office says ticks are found above all in deciduous forests with lush undergrowth and at an altitude of up to 1,500 metres.
TBE-infected ticks can cause the outbreak of two stages of the disease. During a first episode, which occurs seven to 14 days after the sting, patients suffer flu-like symptoms such as headaches, fever, fatigue or joint complaints.
In 5%-15% of those affected, a second stage of the illness develops, which can last for months and may involve symptoms of meningitis or encephalitis. These symptoms can cause paralysis and leave permanent disabilities. About 1% of cases are fatal.
Much more common than tick-borne encephalitis is Lyme disease, also transmitted through tick bites, which must be treated with antibiotics.
More
More
Tick bites and Lyme disease on the rise
This content was published on
Physicians in Switzerland have seen a sharp increase in the number of tick bites as well as cases of Lyme disease this year.
Swiss invention: 90-year anniversary of first T-bar ski lift
This content was published on
On Monday it will be 90 years since the world’s first T-bar ski lift went into service in Davos. This Swiss invention was an instant success.
Iran summons Swiss ambassador over US and Italy arrests
This content was published on
Iran has summoned the Swiss ambassador, who represents US interests, to protest against the arrest in the US and Italy of two Iranians.
Swisscom receives greenlight for acquisition of Vodafone Italia
This content was published on
The takeover of Vodafone Italia by Swisscom is nearing completion. All relevant authorities have now approved the €8 billion (CHF7.45 billion) deal.
Novo Nordisk stock market plunge drags down Swiss device maker Ypsomed
This content was published on
The Danish pharmaceutical giant, Novo Nordisk, faced setbacks on Friday that weighed on the share price of Swiss injection device manufacturer Ypsomed.
Swiss press react to EU deal with mix of euphoria and scepticism
This content was published on
Swiss media reaction to the agreement between Switzerland and the EU varies widely. Some are celebrating, while others worry about what is to come.
Swiss Solidarity donations to tackle child abuse top CHF4 million
This content was published on
Swiss Solidarity, the humanitarian arm of the Swiss Broadcasting Corporation (SBC), has raised over CHF4 million ($4.3 million) to tackle child abuse.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Tick-borne encephalitis cases increase in Switzerland
This content was published on
A significant increase in cases of tick-borne encephalitis (TBE) has been reported by the Swiss health authorities this year.
This content was published on
The current hot summer in Switzerland is being enjoyed not just by people but also by wasps, bees and mosquitos. The organisation is therefore advising people to take precautionary measures, such as not drinking out of cans. The smallest insects cause the biggest problems, SUVA said on Tuesday. Wasps, bees and ticks cause some 20,000…
Meningitis cases from tick bites on the rise in Switzerland
This content was published on
More people in Switzerland have contracted meningitis from tick bites so far this year than at any point in the last decade, according to federal health officials. They are emphasising the need for vaccines to prevent the disease. Speaking with the SonntagsZeitung newspaper, Daniel Koch of the Federal Health Office called the increase in meningitis…
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.